Saliva & Liquid Biopsy Translational Laboratory, Griffith Institute for Drug Discovery, Griffith University, Nathan, Queensland, Australia.
Department of Otolaryngology, Head and Neck Surgery, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
Cancer Med. 2024 Aug;13(16):e70129. doi: 10.1002/cam4.70129.
Head and neck malignancy, and in particular squamous cell carcinoma (SCC), is responsible for a significant disease burden globally. The lack of an optimal in vitro model system to accurately recapitulate in vivo response to therapy in HNSCC remains a challenge. The development of patient-derived three-dimensional tumour cultures, or tumoroids, has enabled improved modelling of the tumour microenvironment through simulation of important characteristics such as tumour hypoxia, cell-cell interactions and nutrient diffusion characteristics.
We performed a comprehensive English-language literature review of current methods of tumoroid development utilising Matrigel and Cultrex Basement Membrane Extract 2 (key terms: tumour organoids, tumoroids, hydrogels, Matrigel, Cultrex, squamous cell carcinoma, head and neck)-two common proprietary murine-derived hydrogels containing extracellular matrix proteins. Nascent literature on the establishment of a novel hydrogel-free platform for tumoroid development as distinct from these existing methods was also explored.
Whilst useful for facilitating cell-matrix interactions and providing a scaffold for three-dimensional cell growth and organisation, murine-derived cell matrix methods were noted to have notable limitations including temperature sensitivity and the medium forming a barrier to analysis of the supernatant. A novel hydrogel-free method of establishing in vitro tumoroid cultures has been subject to experimentation in colorectal but not head and neck malignancy. The absence of a hydrogel provides for the de novo synthesis of extracellular matrix native to the tumour and self-organisation of cells within this scaffold through the use of ultralow attachment plates. This model demonstrates similar structural and physiological properties to native tissue, whilst enabling more accurate biomimicry of the tumour microenvironment for drug testing.
In the absence of prior experimentation on a hydrogel-free method for establishing HNSCC tumoroids, and comparisons between hydrogel and hydrogel-free models, the future development of a comparative protocol encompassing recruitment, collection, processing and analysis represents a valuable opportunity.
头颈部恶性肿瘤,特别是鳞状细胞癌(SCC),在全球范围内造成了巨大的疾病负担。缺乏能够准确再现头颈部鳞状细胞癌对治疗的体内反应的理想体外模型系统仍然是一个挑战。通过模拟肿瘤缺氧、细胞-细胞相互作用和营养扩散特征等重要特征,开发患者来源的三维肿瘤培养物或肿瘤球,已经能够更好地模拟肿瘤微环境。
我们对利用 Matrigel 和 Cultrex 基底膜提取物 2(关键词:肿瘤类器官、肿瘤球、水凝胶、Matrigel、Cultrex、鳞状细胞癌、头颈部)开发肿瘤球的当前方法进行了全面的英语文献回顾——这两种常用的专利鼠源性水凝胶均含有细胞外基质蛋白。还探索了建立与现有方法不同的新型无凝胶肿瘤球开发平台的新兴文献。
尽管有助于促进细胞-基质相互作用,并为三维细胞生长和组织提供支架,但鼠源性细胞基质方法存在明显的局限性,包括温度敏感性以及培养基形成对上清液分析的障碍。一种新的无凝胶方法已用于建立体外肿瘤球培养物的实验,但其尚未应用于头颈部恶性肿瘤。无凝胶的存在促进了肿瘤中天然细胞外基质的从头合成,并通过使用超低附着板使细胞在该支架内自我组织。该模型具有与天然组织相似的结构和生理特性,同时能够更准确地模拟肿瘤微环境进行药物测试。
在缺乏用于建立头颈部鳞状细胞癌肿瘤球的无凝胶方法的前期实验以及水凝胶和无凝胶模型之间的比较的情况下,未来制定一个包括招募、收集、处理和分析的比较方案是一个有价值的机会。